Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 5171-5180 of 10980

Edit search filters
  1. A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury

    Scottsdale/Phoenix, AZ

  2. Primary Breast Oligoprogressive Metastatic Disease Treated with Stereotactic Body Radiation Therapy to Obviate the Need to Change Systemic Therapy (BOSS)

    Rochester, MN, Scottsdale/Phoenix, AZ

  3. Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis

    Rochester, MN

  4. A Study to Assess the Safety, Tolerability, and Pharmacodynamics of SYNB8802 in Healthy Volunteers and in Patients with Enteric Hyperoxaluria

    Rochester, MN

  5. Intrathecal Opioids for Pain Control After Colorectal Resection

  6. PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS

    Rochester, MN

  7. A Study to Evaluate Daratumumab in Treating Transplant-Eligible Participants with Multiple Myeloma

    Jacksonville, FL

  8. A Study to Evaluate the Effectiveness and Safety of Rivaroxaban as Prophylaxis Treatment for Venous Thromboembolism (VTE) in Ambulatory Cancer Patients

    Rochester, MN

  9. Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot

    Rochester, MN

  10. A Study for RNA (Genetic) Analysis in Adult Patients with Eosinophilic Esophagitis

    Rochester, MN

.

Mayo Clinic Footer